VitMode

Epilepsy: Symptoms, Seizure Types, and Treatment — a Complete Overview

Epilepsy isn't one disease but a broad spectrum of disorders with different causes, clinical presentations, and prognoses — from single, mild absence seizures to severe, drug-resistant focal epilepsy. In this overview we explain how seizures are classified under the current ILAE criteria, what EEG diagnosis actually involves, how first-line anti-seizure medications are chosen, and how drug-resistant epilepsy differs from difficult-to-control epilepsy — and what that means in practice for the patient.

AKdr Anna KowalczykSeptember 21, 202614 min read
Table of contents

What epilepsy is — and how it differs from a single seizure

A single epileptic seizure — an episode of abnormal, excessive, or synchronized electrical activity of neurons in the brain — can occur under many circumstances (high fever in a child, severe dehydration, alcohol withdrawal, acute head injury) and does not by itself mean epilepsy. Epilepsy is a lasting tendency of the brain to generate seizures, and under the practical clinical definition it is usually diagnosed after at least two unprovoked seizures more than 24 hours apart, or after a single unprovoked seizure if the risk of another is similarly high as after two seizures (for example, with a clear structural abnormality on brain imaging).

This distinction has practical significance — a single convulsive seizure after a sleepless night and dehydration at a music festival is a completely different clinical situation than recurrent, unprovoked seizures in someone without a clear triggering factor. Epilepsy is one of the most common serious neurological conditions in the world, and its causes are remarkably varied: from genetic factors, through brain developmental abnormalities, stroke, tumors, and central nervous system infections, to epilepsy of unknown cause (idiopathic), where even thorough diagnostic work-up fails to identify a specific underlying condition.

How epileptic seizures are classified — the ILAE 2017 system

The International League Against Epilepsy (ILAE) introduced an updated, operational classification of seizure types in 2017, organizing them by three main criteria: where the seizure begins (focal, generalized, or of unknown onset), the state of consciousness during a focal seizure (retained or impaired awareness), and the dominant symptoms at seizure onset (motor or non-motor).

Instruction manual for the ILAE 2017 operational classification of seizure types

Strong evidence

Fisher RS, Cross JH, French JA et al. (ILAE Commission for Classification and Terminology) · Epilepsia · 2017

The official ILAE document organizes the classification of epileptic seizures along three axes: onset (focal, generalized, unknown), awareness (retained/impaired in focal seizures), and the nature of the initial symptoms (motor, e.g., tonic-clonic, clonic, atonic, myoclonic seizures; non-motor, e.g., absence seizures). The system replaced older, less precise terms such as "simple partial seizure" or "complex partial seizure," introducing clearer clinical terminology now used worldwide.

View study

In practice, this means, for example, that a focal seizure with retained awareness (formerly called "simple partial") may present solely as an unusual sensation, tingling in one limb, or a momentary smell disturbance, without loss of consciousness — something that can be wrongly dismissed by the patient themselves as "a strange feeling" rather than an epileptic seizure. Generalized tonic-clonic seizures (formerly "grand mal"), on the other hand, are the most recognizable — though not the only — form of epilepsy in popular awareness.

Symptoms — why epilepsy doesn't always look the way we think

Myth

Epilepsy always looks the same — it's whole-body convulsions, loss of consciousness, and collapsing to the ground.

Fact

That describes one seizure type — generalized tonic-clonic — not epilepsy as such. Seizures can take the form of a brief "blanking out" with a vacant stare lasting a few to a dozen or so seconds (absence seizures, common in children), a sudden, momentary jerk of a limb without loss of consciousness (myoclonus), a confused, automatic-behavior episode (e.g., lip-smacking, fumbling with objects) with impaired awareness, or even a purely subjective experience — sudden fear, déjà vu, or an unusual smell — with no outwardly visible motor symptoms at all.

This diversity of clinical presentation is one reason epilepsy diagnosis is sometimes delayed, especially with focal seizures without loss of awareness or absence seizures in children, which those around the person may mistakenly interpret as a moment of inattention. Key to diagnosis is gathering a detailed, repeatable pattern of episodes — ideally also described by a witness, since the patient themselves often doesn't remember what happened during a seizure with impaired awareness.

What diagnosis looks like — the role of EEG and imaging studies

The foundation of epilepsy diagnosis remains a detailed clinical history — a description of the seizures themselves, the circumstances in which they occur, and any possible triggering factors — supplemented by electroencephalography (EEG), which records the brain's electrical activity and can detect changes characteristic of epilepsy (e.g., spikes, sharp waves) even between seizures. A standard, routine EEG lasting 20-30 minutes detects epileptiform abnormalities in only some patients with epilepsy — a normal result from a single test does not rule out the diagnosis, which is why, with strong clinical suspicion, repeat testing, sleep-deprived EEG, or long-term video-EEG monitoring is used, especially in cases of diagnostic difficulty or when planning surgical treatment.

Brain MRI is recommended for most adults with newly diagnosed epilepsy to look for a structural cause of the seizures (e.g., hippocampal sclerosis, cortical malformation, effects of stroke or a tumor), which matters both for establishing prognosis and for choosing treatment — and in some cases for determining eligibility for surgical treatment. Blood tests are also typically done to rule out metabolic causes of seizures (electrolyte disturbances, hypoglycemia), which can mimic epilepsy without actually being it.

Pharmacological treatment — how the first-choice medication is selected

The choice of anti-seizure medication (anticonvulsant) depends primarily on the type of seizures and the type of epilepsy (focal vs. generalized), as well as on age, sex, coexisting conditions, and potential interactions with other medications. The goal of treatment is complete seizure control with as few side effects as possible — most patients achieve this with the first or second medication tried.

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy

Strong evidence

Marson A, Burnside G, Appleton R et al. · The Lancet · 2021

A large, multicenter randomized trial (990 participants) compared lamotrigine, levetiracetam, and zonisamide as first-line treatment in newly diagnosed focal epilepsy. Lamotrigine proved more effective than both other drugs in the per-protocol analysis in terms of the proportion of patients achieving 12-month seizure remission, and levetiracetam failed to meet the non-inferiority criterion against lamotrigine in the intention-to-treat analysis. The authors conclude that lamotrigine should remain the first-choice medication in newly diagnosed focal epilepsy, despite the widespread use of levetiracetam in clinical practice.

View study

In generalized epilepsies, including idiopathic generalized epilepsies, valproate remains the medication with the most strongly documented efficacy — with an important caveat: due to the high risk of birth defects and neurodevelopmental disorders in the child, valproate is avoided where possible in women of childbearing age, in favor of alternatives such as lamotrigine or levetiracetam. The decision on which specific medication to use and at what dose always rests with the treating neurologist, who takes the individual patient's profile into account.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

When epilepsy is drug-resistant

Although most patients achieve good seizure control with medication, in some — despite correctly chosen treatment — seizures persist. The International League Against Epilepsy has developed a precise, now widely used definition of this condition.

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

Strong evidence

Kwan P, Arzimanoglou A, Berg AT et al. · Epilepsia · 2010

The ILAE consensus defines drug-resistant epilepsy as failure of adequate trials of two tolerated, appropriately chosen and used anti-seizure medications (as monotherapy or in combination) to achieve sustained seizure freedom. The rationale for this definition is the observation that once two appropriately chosen medications have failed, the probability of achieving full seizure control with further pharmacotherapy adjustments drops significantly, which makes this point a clinically important decision threshold.

View study

What drug resistance means in practice

A diagnosis of drug-resistant epilepsy doesn't mean there are no further options — it's a signal to consider referral to a specialized epilepsy center, where the appropriateness of presurgical evaluation, surgical treatment (e.g., resection of the epileptic focus), vagus nerve stimulation, or a ketogenic diet is assessed — options that, in properly selected patients, can significantly improve seizure control where further medications no longer help.

Living with epilepsy — safety and limitations

Practical aspects of living with epilepsy worth discussing with your treating physician

  • Driving regulations — in most countries a documented seizure-free period is required before you can apply for or keep a driver's license
  • Sleep hygiene and avoiding sleep deprivation, one of the best-documented factors lowering the seizure threshold in many people with epilepsy
  • Caution when bathing and swimming alone — the risk of drowning during a seizure is real and requires practical precautions
  • Interactions of anti-seizure medications with other drugs, including hormonal contraception — some anti-seizure medications (e.g., carbamazepine) reduce the effectiveness of oral contraceptives
  • Pregnancy planning in women with epilepsy should be done in advance, in cooperation with a neurologist, given the teratogenicity of some anti-seizure medications

When a seizure requires immediate medical help

Status epilepticus and other alarming situations

A convulsive seizure lasting longer than 5 minutes, or a series of seizures occurring one after another without regaining full consciousness in between, is status epilepticus — a state of direct danger to life requiring an immediate call for emergency medical help. Urgent medical evaluation is also needed for: a first-ever epileptic seizure in life, an injury sustained during a seizure, a seizure in a pregnant woman, a seizure in a person with diabetes (need to rule out hypoglycemia), and failure to return to full consciousness within roughly ten to a few dozen minutes after convulsions end. This article is educational in nature and does not replace evaluation by a neurologist — decisions about diagnosis, choice, and changes to anti-seizure treatment always belong to the treating physician.

Epilepsy in brief

QuestionShort answer
When does a single seizure mean epilepsy?Usually after 2 unprovoked seizures more than 24h apart, or 1 with a high risk of recurrence
How are seizures classified?By ILAE 2017: focal/generalized/unknown, with retained or impaired awareness
Does EEG always detect epilepsy?No — a single routine EEG can be normal despite epilepsy; video-EEG monitoring is sometimes needed
What's the first-choice medication in focal epilepsy?According to the SANAD II study — lamotrigine
When is epilepsy drug-resistant?After failure of 2 appropriately chosen anti-seizure medications (ILAE 2010 definition)
When is it an emergency?A seizure lasting over 5 minutes, or a series of seizures without regaining consciousness between them (status epilepticus)

Epilepsy — key facts

Our editorial recommendation

Epilepsy remains one of the most socially underestimated neurological conditions — partly because its clinical presentation is far broader than the popular image of convulsions and loss of consciousness suggests. Precise seizure classification, systematic diagnosis, and well-chosen first-line treatment allow most patients to lead fully active lives, and a clear definition of drug resistance provides a concrete, evidence-based point at which it's worth seeking further options rather than more trial and error.

Epilepsy isn't one disease with one presentation — it's a broad spectrum in which precisely identifying the seizure type determines everything that follows: the choice of medication, the prognosis, and the moment when it's worth considering more than just another pill.

Dr. Anna Kowalczyk, VitMode editorial team

Frequently asked questions

Not necessarily — a single seizure can be provoked (e.g., by high fever, dehydration, alcohol withdrawal) and does not by itself mean epilepsy. Diagnosis is usually made after at least two unprovoked seizures more than 24 hours apart, or after one if the risk of recurrence is similarly high as after two episodes.

No — that describes only one seizure type (generalized tonic-clonic). Seizures can take the form of a brief blank stare, a single limb jerk, a confused-behavior episode, or even a purely subjective experience with no visible motor symptoms.

A standard, routine EEG usually lasts 20-30 minutes and records brain activity only within that short window — if no seizure activity occurs during that time, the recording can appear normal despite existing epilepsy. With strong clinical suspicion, repeat testing, sleep-deprived EEG, or longer video-EEG monitoring is used.

It depends on the type of epilepsy. In focal epilepsy, according to the large SANAD II study, lamotrigine proved more effective than levetiracetam and zonisamide in achieving long-term seizure remission. In idiopathic generalized epilepsies, valproate has the most strongly documented efficacy, though it's avoided in women of childbearing age because of risks to the fetus.

Under the 2010 ILAE consensus definition, epilepsy is considered drug-resistant when sustained seizure freedom cannot be achieved despite adequate trials of two tolerated, appropriately chosen and used anti-seizure medications. It's a signal to consider referral to a specialized epilepsy center.

It depends on local regulations, but in most countries a documented, specified seizure-free period is required before applying for or keeping a driver's license. The exact rules and required seizure-free period are worth discussing with your treating neurologist.

Yes — sleep deprivation is one of the best-documented factors lowering the seizure threshold in many people with epilepsy, which is why regular sleep hygiene is an important non-pharmacological part of disease control.

A seizure lasting longer than 5 minutes, or a series of seizures without regaining full consciousness in between, is status epilepticus — it requires an immediate call for emergency medical help, as it is a state of direct danger to life.

Sources

AK

dr Anna Kowalczyk

PhD in Molecular Biology (University of Warsaw), 8 years researching cellular aging

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

Related articles

Lekarz analizujący obraz rezonansu magnetycznego mózgu

The Ketogenic Diet and Drug-Resistant Epilepsy in Children — What Did the First Randomized Trial Show?

Before the ketogenic diet became a popular weight-loss approach, for nearly a hundred years it was — and still is — a serious, medically supervised therapy used in children with drug-resistant epilepsy, meaning epilepsy that can't be controlled despite correctly chosen antiepileptic drugs. In 2008, the first randomized controlled trial was published testing this intervention in a scientifically rigorous way — and it confirmed what neurologists had observed clinically for decades. This is an entirely different context than today's popular use of the keto diet for weight loss, which is easy to forget when seeing the same words applied to both.

11 min

August 27, 2026

Starszy mężczyzna w kapeluszu spacerujący w parku

Exercise and Parkinson's Disease — What Does the Meta-Analysis Show?

Parkinson's disease is a progressive neurodegenerative condition that cannot be reversed or "cured" by exercise alone. Yet a meta-analysis of 18 randomized trials with 901 patients shows that regular aerobic physical activity, carried out alongside pharmacological treatment, is associated with a moderate, statistically significant improvement in motor function. We explain exactly what was measured, how large this effect is, and why exercise remains an addition to therapy — not a replacement for it.

11 min

August 27, 2026

Wózek inwalidzki przy szklanych drzwiach w korytarzu szpitalnym

Vitamin D and Multiple Sclerosis — Does Supplementation Reduce Relapse Risk?

Low vitamin D levels and limited sun exposure have long been linked in observational studies to a higher risk and prevalence of multiple sclerosis (MS). This led researchers to ask whether vitamin D supplementation could actually reduce the number of disease relapses or slow the accumulation of disability in people already living with MS. A 2021 meta-analysis of nine randomized trials gave an answer that will surprise many — and shows just how large the gap can be between a strong observational association and a proven effect of intervention.

11 min

August 27, 2026

Kobieta z zamkniętymi oczami trzymająca się za skronie

Migraine: Causes, Mechanism, and Treatment — a Full Overview

Migraine isn't just a "bad headache" — it's a distinct neurological disease that, according to current data, affects 14-15% of the global population and is one of the leading causes of pain-related disability worldwide. In this overview we explain how migraine with aura differs from migraine without aura, what's actually known about triggers, how triptans and the new generation of CGRP-inhibiting drugs work, and when a headache warrants urgent evaluation rather than just a painkiller.

14 min

September 21, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.